Background: the aim of the study was to analyze all-cause mortality and predictors of long-term survival after myocardial revascularization for ischemic cardiomyopathy.
Method: data of 101 patients (mean age, 63.86 years; age range, 30–85 years; 92% male), operated on with stable coronary artery disease and left ventricular ejection fraction <30% between April 2000 and June 2010, were analyzed.
Results: operative mortality was 1.9% (2/101). There was a significant improvement in left ventricular ejection fraction from 25.99% ± 3.8% preoperatively to 34% ± 12% postoperatively (p < 0.0001). The mean duration of follow-up was 56.3 ± 33 months, and it was 97% complete (98/101). There were 18/96 (18.75%) late deaths. Overall actuarial survival at 1, 3, 5, and 10 years was 96%, 89%, 83% and 75%, respectively. Univariate predictors of late death were preoperative arrhythmia, cerebrovascular disease, peripheral vascular disease, and logistic EuroSCORE. Multivariate predictors of late death were cerebrovascular disease and preoperative arrhythmia.
Conclusion: our study suggests that myocardial revascularization for ischemic cardiomyopathy improves left ventricular ejection fraction and is associated with favorable long-term survival. Patients with cerebrovascular disease and preoperative arrhythmias had poorer outcomes.
BartBAShawLKMcCantsCBJrFortinDFLeeKLCaliffRM. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol1997; 30: 1002–1008.
2.
GheorghiadeMSopkoGDe LucaLVelazquezEJParkerJDBinkleyPF. Navigating the crossroads of coronary heart disease and heart failure. Circulation2006; 114: 1202–1213.
3.
LouieHWLaksHMilgalterEDrinkwaterDCJrHamiltonMABrunkenRC. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation1991; 84(Suppl III): 290–295.
4.
ElefteriadesJATolisGJrLeviEMillsLKZaretBL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol1993; 22: 1411–1417.
5.
ShahPJHareDLRamanJSGordonIChanRKHorowitzJD. Survival after myocardial revascularisation for ischemic cardiomyopathy: a prospective ten-year follow-up study. J Thorac Cardiovasc Surg2003; 126: 1320–1327.
6.
GheorghiadeMFlahertyJDFonarowGCDesaiRVLeeRMcGiffinD. Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure. Int J Cardiol2011; 151: 69–75.
7.
FraudSPethigKFrankeUWahlersTHarringerWCremerJ. Ten year survival after heart transplantation: palliative procedure or successful long term treatment?Heart1999; 82: 47–51.
8.
RossiJSFlahertyJDFonarowGCNunezEGattis StoughWAbrahamWT. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organised Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). Eur J Heart Fail2008; 10: 1215–1223.
9.
VelazquezEJLeeKLDejaMAJainASopkoGMarchenkoA. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med2011; 364: 1607–1616.
10.
BuszmanPSzkrobkaIGruszkaAParmaRTenderaZLeskoB. Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy. Am J Cardiol2007; 99: 36–41.
11.
MorrisonDASethiGSacksJHendersonWGroverFSedlisS. Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol2002; 39: 266–273.
12.
AldermanELFisherLDLitwinPKaiserGCMyersWOMaynardC. Results of coronary artery surgery in patients with poor ventricular function (CASS). Circulation1983; 68: 785–795.
13.
SalatiMLemmaMDi MattiaDGDannaPCialfiASalvaggioA. Myocardial revascularization in patients with ischemic cardiomyopathy: functional observations. Ann Thorac Surg1997; 64: 1728–1734.
14.
WeintraubWSClementsSDJrCriscoLVGuytonRACraverJMJonesEL. Twenty-year survival after coronary artery surgery: an institutional perspective from Emory University. Circulation2003; 107: 1271–1278.
15.
MickleboroughLLCarsonSTamarizMIvanovJ. Results of revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg2000; 119: 550–557.
16.
NgaageDLSchaffHVMullanyCJSundtTMDearaniJABarnesS. Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting?J Thorac Cardiovasc Surg2007; 133: 182–189.
17.
QuaderMAMcCarthyPMGillinovAMAlsterJMCosgroveDMLytleBW. Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting?Ann Thorac Surg2004; 77: 1514–1524.
18.
TrachiotisGDWeintraubWSJohnstonTSJonesELGuytonRACraverJM. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg1998; 66: 1632–1639.
19.
MaltaisSSchaffHVDalyRCSuriRMDearaniJASundtTM. Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival. J Thorac Cardiovasc Surg2011; 142: 995–1001.
20.
YoonDYSmediraNGNowickiERHoercherKJRajeswaranJBlackstoneEH. Decision support in surgical management of ischemic cardiomyopathy. J Thorac Cardiovasc Surg2010; 139: 283–293.
